Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Darina Očadlíková"'
Autor:
Darina Ocadlikova, Giulia Corradi, Dorian Forte, Gianluca Cristiano, Michele Cavo, Antonio Curti
Publikováno v:
HemaSphere, Vol 7, p e97655cf (2023)
Externí odkaz:
https://doaj.org/article/299a6dd7fb8040a1b58dac1a7afb502f
Autor:
Darina Ocadlikova, Mariangela Lecciso, Javier Martin Broto, Katia Scotlandi, Michele Cavo, Antonio Curti, Emanuela Palmerini
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundHigh-grade sarcomas are a heterogeneous group of aggressive tumors arising in bone and soft tissues. After relapse, treatment options are limited. The multi-targeted receptor tyrosine kinase inhibitors (TKIs) sunitinib and inhibitor of PD-1
Externí odkaz:
https://doaj.org/article/f47503fa1f334b9dbe83c6daf7a0ec6b
Autor:
Giulia Corradi, Carmen Baldazzi, Darina Očadlíková, Giovanni Marconi, Sarah Parisi, Nicoletta Testoni, Carlo Finelli, Michele Cavo, Antonio Curti, Marilena Ciciarello
Publikováno v:
Stem Cell Research & Therapy, Vol 9, Iss 1, Pp 1-15 (2018)
Abstract Background Mesenchymal stromal cells (MSCs) are an essential element of the bone marrow (BM) microenvironment, playing a crucial function in regulating hematopoietic stem cell proliferation and differentiation. Recent findings have outlined
Externí odkaz:
https://doaj.org/article/b27bed38a7294665a9ababb5c5ba0f88
Autor:
Sara Trabanelli, Mariangela Lecciso, Valentina Salvestrini, Michele Cavo, Darina Očadlíková, Roberto M. Lemoli, Antonio Curti
Publikováno v:
Journal of Immunology Research, Vol 2015 (2015)
In the last years, dendritic cells (DC) have been evaluated for antitumor vaccination. Although DC-based vaccines have raised great expectations, their clinical translation has been largely disappointing. For these results, several explanations
Externí odkaz:
https://doaj.org/article/591510b08fbf4adcbae8a69e8031843d
Autor:
Sarah Parisi, Chiara Sartor, Gianluca Cristiano, Antonio Curti, Annalisa Talami, Emanuela Ottaviani, Jayakumar Vadakekolathu, Matteo Olivi, Sarah Wagner, Simone Ragaini, Michele Cavo, Cristina Papayannidis, Giovanni Marconi, Stefania Paolini, Jacopo Nanni, Sergio Rutella, Darina Očadlíková, Giulia Corradi, Marilena Ciciarello
Publikováno v:
Blood Advances
Key Points The semaphorin receptor PLXNC1 is an IDO1-interacting gene and a strong predictor of survival in AML.An IDO1-related immune gene signature, including PLXNC1, predicts survival in AML.
Visual Abstract
The contribution of the bone
Visual Abstract
The contribution of the bone
Autor:
Giulia Corradi, Dorian Forte, Gianluca Cristiano, Andrea Polimeno, Marilena Ciciarello, Valentina Salvestrini, Lorenza Bandini, Valentina Robustelli, Emanuela Ottaviani, Michele Cavo, Darina Ocadlikova, Antonio Curti
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Acute myeloid leukemia (AML) is an aggressive heterogeneous disease characterized by several alterations of the immune system prompting disease progression and treatment response. The therapies available for AML can affect lymphocyte function, limiti
Externí odkaz:
https://doaj.org/article/a5d55294093e4929a53b57474c48442f
Autor:
Sergio Amadori, Mariangela Lecciso, Giuseppe Visani, Darina Očadlíková, Federica Loscocco, Antonio Curti, Michele Cavo, Alessandro Isidori
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncology, Vol 9 (2019)
In solid tumors and hematological malignancies, including acute myeloid leukemia, some chemotherapeutic agents, such as anthracyclines, have proven to activate an immune response via dendritic cell-based cross-priming of anti-tumor T lymphocytes. Thi
Autor:
Simone Ragaini, Marilena Ciciarello, Stefania Paolini, Emanuela Ottaviani, Sarah Wagner, Antonio Curti, Jayakumar Vadakekolathu, Michele Cavo, Sergio Rutella, Matteo Olivi, Darina Očadlíková, Giulia Corradi, Jacopo Nanni, Gianluca Cristiano, Annalisa Talami, Cristina Papayannidis, Sarah Parisi, Chiara Sartor, Giovanni Marconi
Publikováno v:
Blood. 134:5193-5193
Introduction: ELN intermediate-risk AML poses considerable challenges to clinicians both in terms of accurate prognostication and optimal treatment. Indoleamine 2,3-dioxygenase 1 (IDO1) plays a central role as a mediator of immune tolerance in AML th
Autor:
Sabina Sangaletti, Darina Očadlíková, Antonio Curti, Mario P. Colombo, Serenella Casella, Elena De Marchi, Elisa Orioli, Michele Cavo, Elena Adinolfi, Francesco Di Virgilio, Ines Pintao, Anna Pegoraro
Publikováno v:
Blood. 134:2332-2332
Background: Although the recent advances have allowed the discovery of new and less toxic forms of treatment for acute myeloid leukemia (AML), chemotherapy remains as one of the most used treatments. Some chemotherapeutic agents can induce a type of
Autor:
Mariangela Lecciso, Valeria Giudice, Maria Rosa Motta, Giuseppe Bandini, Loredana Ruggeri, Andrea Velardi, Russel Edward Lewis, Darina Očadlíková, Francesca Bonifazi, Sara Trabanelli, Simonetta Rizzi, Cristina Papayannidis, Andrea Bontadini, Roberto M. Lemoli, Giovanni Martinelli, Michele Cavo, Elena Urbani, Sarah Parisi, Elisa Dan, F. Fruet, Antonio Curti
In acute myeloid leukemia (AML), alloreactive natural killer (NK) cells are crucial mediators of immune responses after haploidentical stem cell transplantation. Allogeneic NK cell infusions have been adoptively transferred with promising clinical re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbdafaff4833a7e0ebdac70510f7766b
http://hdl.handle.net/11567/861649
http://hdl.handle.net/11567/861649